Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a major health issue worldwide, frequently associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease, which is characterized by lipid accumulation in hepatocytes, which can progress to non-alcoholic steatohepatitis (NASH)...
Saved in:
Main Authors: | Fougerat, Anne, Montagner, Alexandra, Loiseau, Nicolas, Guillou, Hervé, Wahli, Walter |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/144925 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
by: Tan, Chek Kun, et al.
Published: (2017) -
Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology
by: Manickam, Ravikumar, et al.
Published: (2017) -
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
by: Tan, Nguan Soon, et al.
Published: (2017) -
An aPPARent functional consequence in skeletal muscle physiology via peroxisome proliferator-activated receptors
by: Liao, Zehuan, et al.
Published: (2018) -
Single gene contributions: Genetic variants of peroxisome proliferator-activated receptor (isoforms α, β/δ and γ) and mechanisms of dyslipidemias
by: Yong, E.L., et al.
Published: (2011)